Silymarin - Hepatobiliary agent- (June 1995)
Drug Name:
Silymarin - Hepatobiliary agent- (June 1995)
List Of Brands:
Indication Type Description:
Drug Interaction:
None reported.
Indication:
Chronic active hepatitis
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Silymarin Hepatoprotective June 1995
Adverse Reaction:
Occasional laxative effect.
Contra-Indications:
H/O hypersensitivity,pregnancy and lactation.
Special precautions:
Safety in pregnancy, lactation, and in children not established.
Dosages/ Overdosage Etc:
Date of Approval - June 1995
Indication-
Chronic active hepatitis
Dosage-
70mg 2- 3 times daily Severe cases (serum bilirubin ) over 10mg- 140mg 2- 3 times daily for 6 weeks or as required